ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urea Cycle Disorder (UCD) Drugs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-18B18463
Home | Market Reports | Health| Health Conditions
Global Urea Cycle Disorder UCD Drugs Market Research Report 2024
BUY CHAPTERS

Global Urea Cycle Disorder (UCD) Drugs Market Research Report 2024

Code: QYRE-Auto-18B18463
Report
October 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Group
UCD
Horizon Pharma
Zhaoke Pharmaceutical
Kyowa Hakko Bio
Recordati Rare Diseases
Immedica Pharma
Weijian Pharmaceutical
5

Urea Cycle Disorder (UCD) Drugs Market

Urea cycle disorders are a group of metabolic diseases in which the levels of circulating ammonia or glutamine are elevated due to functional loss or abnormality of enzymes or transporters involved in the urea cycle. Symptoms of this disease may appear at any age, and the earlier the symptoms appear, the more severe the disease. UCD patients may experience hyperammonemia crisis, which is when the ammonia level in the blood is too high, which may cause irreversible brain damage, coma or death. In addition to hyperammonemia crisis, UCD patients may also experience other symptoms such as vomiting, food refusal, irritability, low muscle tone, and delayed motor and intellectual development. The probability of this group of metabolic diseases occurring in newborns is 1/35,000.
The global Urea Cycle Disorder (UCD) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Urea Cycle Disorder (UCD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urea Cycle Disorder (UCD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urea Cycle Disorder (UCD) Drugs include Horizon Pharma, Immedica Pharma, Weijian Pharmaceutical, Zhaoke Pharmaceutical, Kyowa Hakko Bio, Recordati Rare Diseases, 5, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urea Cycle Disorder (UCD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urea Cycle Disorder (UCD) Drugs.
The Urea Cycle Disorder (UCD) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Urea Cycle Disorder (UCD) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urea Cycle Disorder (UCD) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Urea Cycle Disorder (UCD) Drugs Market Report

Report Metric Details
Report Name Urea Cycle Disorder (UCD) Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Horizon Pharma, Immedica Pharma, Weijian Pharmaceutical, Zhaoke Pharmaceutical, Kyowa Hakko Bio, Recordati Rare Diseases, 5
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Urea Cycle Disorder (UCD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Urea Cycle Disorder (UCD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Urea Cycle Disorder (UCD) Drugs Market report?

Ans: The main players in the Urea Cycle Disorder (UCD) Drugs Market are Horizon Pharma, Immedica Pharma, Weijian Pharmaceutical, Zhaoke Pharmaceutical, Kyowa Hakko Bio, Recordati Rare Diseases, 5

What are the Application segmentation covered in the Urea Cycle Disorder (UCD) Drugs Market report?

Ans: The Applications covered in the Urea Cycle Disorder (UCD) Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Urea Cycle Disorder (UCD) Drugs Market report?

Ans: The Types covered in the Urea Cycle Disorder (UCD) Drugs Market report are Glycerol Phenylbutyrate, Sodium Phenylbutyrate, Sodium Benzoate, Other

Recommended Reports

Metabolic Disorder Treatments

Liver and Urea Diagnostics

Genetic and Metabolism Disorders

1 Urea Cycle Disorder (UCD) Drugs Market Overview
1.1 Product Definition
1.2 Urea Cycle Disorder (UCD) Drugs by Type
1.2.1 Global Urea Cycle Disorder (UCD) Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.2.4 Sodium Benzoate
1.2.5 Other
1.3 Urea Cycle Disorder (UCD) Drugs by Application
1.3.1 Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Urea Cycle Disorder (UCD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Urea Cycle Disorder (UCD) Drugs Revenue 2019-2030
1.4.2 Global Urea Cycle Disorder (UCD) Drugs Sales 2019-2030
1.4.3 Global Urea Cycle Disorder (UCD) Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Urea Cycle Disorder (UCD) Drugs Market Competition by Manufacturers
2.1 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Urea Cycle Disorder (UCD) Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Enter into This Industry
2.8 Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation and Trends
2.8.1 Global Urea Cycle Disorder (UCD) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Urea Cycle Disorder (UCD) Drugs Players Market Share by Revenue
2.8.3 Global Urea Cycle Disorder (UCD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Urea Cycle Disorder (UCD) Drugs Market Scenario by Region
3.1 Global Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2019-2030
3.2.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2019-2024
3.2.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2025-2030
3.3 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2019-2030
3.3.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2019-2024
3.3.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2025-2030
3.4 North America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.4.1 North America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2030)
3.4.3 North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.5.1 Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2030)
3.5.3 Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.7.1 Latin America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2030)
3.7.3 Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2019-2030)
4.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2019-2024)
4.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2025-2030)
4.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2019-2030)
4.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2019-2030)
4.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2019-2024)
4.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2025-2030)
4.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Urea Cycle Disorder (UCD) Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2019-2030)
5.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2019-2024)
5.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2025-2030)
5.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2019-2030)
5.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2019-2030)
5.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2019-2024)
5.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2025-2030)
5.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Urea Cycle Disorder (UCD) Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Horizon Pharma
6.1.1 Horizon Pharma Company Information
6.1.2 Horizon Pharma Description and Business Overview
6.1.3 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.1.5 Horizon Pharma Recent Developments/Updates
6.2 Immedica Pharma
6.2.1 Immedica Pharma Company Information
6.2.2 Immedica Pharma Description and Business Overview
6.2.3 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.2.5 Immedica Pharma Recent Developments/Updates
6.3 Weijian Pharmaceutical
6.3.1 Weijian Pharmaceutical Company Information
6.3.2 Weijian Pharmaceutical Description and Business Overview
6.3.3 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.3.5 Weijian Pharmaceutical Recent Developments/Updates
6.4 Zhaoke Pharmaceutical
6.4.1 Zhaoke Pharmaceutical Company Information
6.4.2 Zhaoke Pharmaceutical Description and Business Overview
6.4.3 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.4.5 Zhaoke Pharmaceutical Recent Developments/Updates
6.5 Kyowa Hakko Bio
6.5.1 Kyowa Hakko Bio Company Information
6.5.2 Kyowa Hakko Bio Description and Business Overview
6.5.3 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.5.5 Kyowa Hakko Bio Recent Developments/Updates
6.6 Recordati Rare Diseases
6.6.1 Recordati Rare Diseases Company Information
6.6.2 Recordati Rare Diseases Description and Business Overview
6.6.3 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.6.5 Recordati Rare Diseases Recent Developments/Updates
6.7 5
6.7.1 5 Company Information
6.7.2 5 Description and Business Overview
6.7.3 5 Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 5 Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.7.5 5 Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urea Cycle Disorder (UCD) Drugs Industry Chain Analysis
7.2 Urea Cycle Disorder (UCD) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urea Cycle Disorder (UCD) Drugs Production Mode & Process
7.4 Urea Cycle Disorder (UCD) Drugs Sales and Marketing
7.4.1 Urea Cycle Disorder (UCD) Drugs Sales Channels
7.4.2 Urea Cycle Disorder (UCD) Drugs Distributors
7.5 Urea Cycle Disorder (UCD) Drugs Customers
8 Urea Cycle Disorder (UCD) Drugs Market Dynamics
8.1 Urea Cycle Disorder (UCD) Drugs Industry Trends
8.2 Urea Cycle Disorder (UCD) Drugs Market Drivers
8.3 Urea Cycle Disorder (UCD) Drugs Market Challenges
8.4 Urea Cycle Disorder (UCD) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Group
UCD
Horizon Pharma
Zhaoke Pharmaceutical
Kyowa Hakko Bio
Recordati Rare Diseases
Immedica Pharma
Weijian Pharmaceutical
5
List of Tables
 Table 1. Global Urea Cycle Disorder (UCD) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Urea Cycle Disorder (UCD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorder (UCD) Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Horizon Pharma Company Information
 Table 71. Horizon Pharma Description and Business Overview
 Table 72. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product
 Table 74. Horizon Pharma Recent Developments/Updates
 Table 75. Immedica Pharma Company Information
 Table 76. Immedica Pharma Description and Business Overview
 Table 77. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product
 Table 79. Immedica Pharma Recent Developments/Updates
 Table 80. Weijian Pharmaceutical Company Information
 Table 81. Weijian Pharmaceutical Description and Business Overview
 Table 82. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
 Table 84. Weijian Pharmaceutical Recent Developments/Updates
 Table 85. Zhaoke Pharmaceutical Company Information
 Table 86. Zhaoke Pharmaceutical Description and Business Overview
 Table 87. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
 Table 89. Zhaoke Pharmaceutical Recent Developments/Updates
 Table 90. Kyowa Hakko Bio Company Information
 Table 91. Kyowa Hakko Bio Description and Business Overview
 Table 92. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product
 Table 94. Kyowa Hakko Bio Recent Developments/Updates
 Table 95. Recordati Rare Diseases Company Information
 Table 96. Recordati Rare Diseases Description and Business Overview
 Table 97. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product
 Table 99. Recordati Rare Diseases Recent Developments/Updates
 Table 100. 5 Company Information
 Table 101. 5 Description and Business Overview
 Table 102. 5 Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. 5 Urea Cycle Disorder (UCD) Drugs Product
 Table 104. 5 Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Urea Cycle Disorder (UCD) Drugs Distributors List
 Table 108. Urea Cycle Disorder (UCD) Drugs Customers List
 Table 109. Urea Cycle Disorder (UCD) Drugs Market Trends
 Table 110. Urea Cycle Disorder (UCD) Drugs Market Drivers
 Table 111. Urea Cycle Disorder (UCD) Drugs Market Challenges
 Table 112. Urea Cycle Disorder (UCD) Drugs Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Urea Cycle Disorder (UCD) Drugs
 Figure 2. Global Urea Cycle Disorder (UCD) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Urea Cycle Disorder (UCD) Drugs Market Share by Type: 2023 & 2030
 Figure 4. Glycerol Phenylbutyrate Product Picture
 Figure 5. Sodium Phenylbutyrate Product Picture
 Figure 6. Sodium Benzoate Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Urea Cycle Disorder (UCD) Drugs Market Share by Application: 2023 & 2030
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Urea Cycle Disorder (UCD) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Urea Cycle Disorder (UCD) Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Urea Cycle Disorder (UCD) Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. Urea Cycle Disorder (UCD) Drugs Report Years Considered
 Figure 18. Urea Cycle Disorder (UCD) Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Urea Cycle Disorder (UCD) Drugs Players: Market Share by Revenue in Urea Cycle Disorder (UCD) Drugs in 2023
 Figure 21. Urea Cycle Disorder (UCD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2019-2030)
 Figure 55. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2019-2030)
 Figure 58. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. Urea Cycle Disorder (UCD) Drugs Value Chain
 Figure 60. Urea Cycle Disorder (UCD) Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Urea Cycle Disorders UCD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urea Cycle Disorder Agent Market Research Report 2024
Global N Acetylglutamate Synthetase Deficiency NAGSD Market Research Report 2024
Global Acute Hyperammonemia Treatment Drugs Market Research Report 2024
Global Drugs to Treat Urea Cycle Disorders Market Research Report 2024
Global Argininemia Drugs Market Insights Forecast to 2030
Global Arginase Deficiency Therapeutics Market Insights Forecast to 2030
Global Arginase Deficiency Treatment Market Insights Forecast to 2030
Global Argininemia Treatment Market Insights Forecast to 2030
Global Arginase Deficiency Drugs Market Insights Forecast to 2030
Ornithine Transcarbamylase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urea Cycle Disorders Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperammonemia Medication Market Research Report 2024
Wilson s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inherited Metabolic Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolic Disease Therapeutics Market Research Report 2025
Amino Acid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Metabolic Disorders Therapeutics Market Research Report 2024
Global Metabolic Disease Drugs Market Research Report 2025
Amino Acid Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions